西黄丸在乳腺癌中的应用研究进展  

Application of Xihuang Pill in Breast Cancer

作　　者：李敏[1] 冯帅[1] 王德民 李峰[1] Li Min;Feng Shuai;Wang Demin;Li Feng(Shandong University of Traditional Chinese Medicine,Jinan 250000,China)

机构地区：[1]山东中医药大学,山东济南250000

出　　处：《亚太传统医药》2020年第3期195-197,共3页Asia-Pacific Traditional Medicine

基　　金：山东省重点研发计划项目(2016GSF202023)。

摘　　要：西黄丸作为传统的抗癌名方,由牛黄、麝香、乳香、没药四味中药组成,广泛应用于乳腺癌、肝癌、肺癌等多种恶性肿瘤的治疗。对西黄丸在乳腺癌中的临床联合治疗及作用机理概况进行整理总结,为该药的进一步开发与研究奠定理论基础,为乳腺癌治疗药物的开发提供依据。As a traditional anticancer prescription,Xihuang Pill has been widely used in the past decade.It consists of Chinese medicines such as bezoar,musk,frankincense and myrrh.Widely used in the treatment of a variety of malignant tumors.This article summarizes the application of Xihuang Pill in breast cancer,summary of the mechanism of action of Xihuang Pill in the treatment of breast cancer,Provide reference for further research of this drug,and provide a basis for the development of breast cancer therapeutic drugs.

关 键 词：西黄丸 抗肿瘤 乳腺癌 作用机制 

分 类 号：R285.3[医药卫生—中药学] R271.44[医药卫生—中医学]